Labeler
Outlook Therapeutics, Inc. NDC Codes
Outlook Therapeutics, Inc. lists 1 finished drug product in the FDA NDC Directory under NDC labeler code 82491.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Lytenava
- Active ingredients
- Bevacizumab
- NDC labeler codes
- 82491
- Strengths
- Bevacizumab 1.25 mg/1
- Dosage forms
- Injection
- Routes
- Intravitreal
- Drug classes (FDA established)
- Vascular Endothelial Growth Factor Inhibitor
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 1
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Lytenavabevacizumab-vikg | Bevacizumab 1.25 mg/1 | InjectionIntravitreal | 82491-025 | 82491-0025-10 | — |
Outlook Therapeutics, Inc.: common questions
- What is Outlook Therapeutics, Inc.'s NDC labeler code?
- 82491. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Outlook Therapeutics, Inc.?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.